<DOC>
	<DOCNO>NCT02078882</DOCNO>
	<brief_summary>The purpose study determine abatacept ( Orencia ) effective patient primary biliary cirrhosis respond adequately standard treatment ursodeoxycholic acid ( UDCA , Urso , Ursodiol , Actigall ) .</brief_summary>
	<brief_title>Study Abatacept ( Orencia ) Treat Primary Biliary Cirrhosis</brief_title>
	<detailed_description>This open label , active treatment trial ass efficacy safety abatacept subject PBC incomplete biochemical response UDCA . In trial , 20 subject PBC incomplete biochemical response UDCA assign treatment weekly subcutaneous injection 125 mg abatacept . The treatment phase study last 24 week off-treatment follow Week 36 . Inclusion criterion include : - Confirmed diagnosis PBC - Alkaline phosphatase &gt; 1.67 time upper limit normal 6 month treatment UDCA</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Confirmed PBC diagnosis base upon least 2 3 criterion 1 . Antimitochondrial antibody ( AMA ) titer &gt; 1:40 2 . Alkaline phosphatase &gt; 1.5 time upper limit normal least 6 month 3 . Liver biopsy finding consistent PBC Incomplete response UDCA define alkaline phosphatase &gt; 1.67 X upper limit normal 6 month UDCA minimum dose 13 mg/kg/d Taking stable dose UDCA least 3 month prior Day 0 aspartate aminotransferase ( AST ) alanine aminotransferase ALT &lt; 5 time upper limit normal Presence concomitant liver diseases include viral hepatitis , primary sclerosing cholangitis , alcoholic liver disease , Wilson 's disease , hemochromatosis , Gilbert 's syndrome . Prior liver transplantation Decompensated liver disease Use immunosuppressant within 6 month Day 0 Use biologic agent within 12 month Day 0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Primary Biliary Cirrhosis</keyword>
	<keyword>Ursodeoxycholic acid</keyword>
	<keyword>Abatacept</keyword>
	<keyword>Cytotoxic T-Lymphocyte Antigen 4 ( CTLA-4 )</keyword>
</DOC>